| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9845 |
| Human Intestinal Absorption | HIA+ | 0.9765 |
| Caco-2 Permeability | Caco2+ | 0.6086 |
| P-glycoprotein Substrate | Non-substrate | 0.7802 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8704 |
| Non-inhibitor | 0.9705 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9015 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8386 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8477 |
| CYP450 2D6 Substrate | Non-substrate | 0.9184 |
| CYP450 3A4 Substrate | Non-substrate | 0.6639 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.6951 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.5928 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9267 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5000 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9249 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7332 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9774 |
| Non-inhibitor | 0.9496 |
| AMES Toxicity | Non AMES toxic | 0.8814 |
| Carcinogens | Non-carcinogens | 0.6029 |
| Fish Toxicity | High FHMT | 0.9941 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9952 |
| Honey Bee Toxicity | High HBT | 0.6516 |
| Biodegradation | Not ready biodegradable | 0.7962 |
| Acute Oral Toxicity | III | 0.7071 |
| Carcinogenicity (Three-class) | Non-required | 0.5684 |